
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home - 2
Reveal Less popular Authentic Realities You Didn't Learn in School - 3
December’s full moon is the last supermoon of the year. Here’s what to know - 4
Where You Could Sleep With Snorlax in Japan, From MIMARU’s Pokémon Rooms to Grand Hyatt Tokyo’s Limited Pokémon Suite - 5
Experience Sports in Dubai: A Daredevil's Aide
The best ice packs for coolers of 2026, tested and reviewed
Grasping the Qualifications Among Separation and Dissolution
Rediscovering Euphoria: Individual Accounts of Conquering Despondency
A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue
Floods, Landslides Triggered By Heavy Rain In Afghanistan Leave 77 Dead In 10 days, Authorities Say
Idris Elba is the king of the stress-watch
Liste des pr\u00eats qui ne n\u00e9cessitent pas de remboursement
Russian billionaire says 12-hour days and 6-day workweeks could help save the economy
Famous Network programs in Europe and America












